SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form POS AM - Post-Effective amendments for registration statement:
SEC Accession No. 0001213900-23-089018
Filing Date
2023-11-21
Accepted
2023-11-21 10:36:37
Documents
5

Document Format Files

Seq Description Document Type Size
1 POST-EFFECTIVE AMENDMENT NO. 2 TO FORM F-1 ea188734-posam_neurosense.htm POS AM 378900
2 2018 SHARE INCENTIVE PLAN ea188734ex10-2_neurosense.htm EX-10.2 136167
3 CONSENT OF SOMEKH CHAIKIN (MEMBER FIRM OF KPMG INTERNATIONAL), INDEPENDENT REGIS ea188734ex23-1_neurosense.htm EX-23.1 1890
4 GRAPHIC image_001.jpg GRAPHIC 6619
5 GRAPHIC image_002.jpg GRAPHIC 12357
  Complete submission text file 0001213900-23-089018.txt   544352
Mailing Address 11 HAMENOFIM ST. BUILDING B HERZLIYA L3 4672562
Business Address 11 HAMENOFIM ST. BUILDING B HERZLIYA L3 4672562 972-9-9531142
NeuroSense Therapeutics Ltd. (Filer) CIK: 0001875091 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: POS AM | Act: 33 | File No.: 333-260338 | Film No.: 231425063
SIC: 2834 Pharmaceutical Preparations